Introducing Ncardia’s IO Safety Panel, a human iPSC-based platform designed to evaluate functional toxicity across multiple relevant tissues within a single, integrated workflow. By combining cardiac and multi-tissue safety readouts, it supports earlier, data-driven decisions and reduces translational uncertainty in immuno-oncology development.
iPSC Products
Physiologically relevant and fully functional cell models, manufactured to scale and readily available.
iPSC Services
Human iPSC-based platforms combining physiologically relevant models with robust and scalable assays to help you select the best drug candidates.
Insights Into iPSC Technology
Advancing cardiovascular drug discovery with iPSC-Derived 3D cardiac microtissues in High-Throughput Screening
Development of a robust and scalable iPSC platform for predictions of efficacy and in vivo toxicity of RNA therapeutics early in the drug discovery pipeline
Building manufacturing processes for reproducible, multi-yeariPSC-based drug screening
Human iPSC Tri-Culture for Alzheimer’s Disease Poster